Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Ezzat

Showing results (121-130 of 249) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineageShun Jiang Yu, Lei Zheng, Marc Ladanyi, et al.
Endocrine Pathology|July 27, 2007
Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncologyNabeel Y Y Al Brahim, Gloria Rambaldini, Shereen Ezzat, et al.
Frontiers in Endocrinology|November 21, 2018
Intrathyroidal Parathyroid Carcinoma: An Atypical Thyroid LesionNoran Alharbi, Sylvia L Asa, Marta Szybowska, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 7, 2004
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cellsShunjiang Yu, Lei Zheng, Denny K Trinh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 24, 2007
Clinical predictors of advanced sellar massesGloria M Rambaldini, Sonia Butalia, Shereen Ezzat, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2005
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegalyShelly Bhayana, Gillian L Booth, Sylvia L Asa, et al.
Endocrinology|August 21, 2004
Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancerAlan P B Dackiw, Shereen Ezzat, Ping Huang, et al.
The Journal of Clinical Investigation|January 10, 2002
Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesisShereen Ezzat, Lei Zheng, Xian-Feng Zhu, et al.
Clinical Endocrinology|May 15, 2009
A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegalyPeter J Trainer, Shereen Ezzat, Gwyn A D'Souza, et al.
Plos Genetics|December 17, 2011
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesisToru Tateno, Sylvia L Asa, Lei Zheng, et al.
Pageof 25

Showing results (121-130 of 249) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineageShun Jiang Yu, Lei Zheng, Marc Ladanyi, et al.
Endocrine Pathology|July 27, 2007
Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncologyNabeel Y Y Al Brahim, Gloria Rambaldini, Shereen Ezzat, et al.
Frontiers in Endocrinology|November 21, 2018
Intrathyroidal Parathyroid Carcinoma: An Atypical Thyroid LesionNoran Alharbi, Sylvia L Asa, Marta Szybowska, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 7, 2004
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cellsShunjiang Yu, Lei Zheng, Denny K Trinh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 24, 2007
Clinical predictors of advanced sellar massesGloria M Rambaldini, Sonia Butalia, Shereen Ezzat, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2005
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegalyShelly Bhayana, Gillian L Booth, Sylvia L Asa, et al.
Endocrinology|August 21, 2004
Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancerAlan P B Dackiw, Shereen Ezzat, Ping Huang, et al.
The Journal of Clinical Investigation|January 10, 2002
Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesisShereen Ezzat, Lei Zheng, Xian-Feng Zhu, et al.
Clinical Endocrinology|May 15, 2009
A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegalyPeter J Trainer, Shereen Ezzat, Gwyn A D'Souza, et al.
Plos Genetics|December 17, 2011
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesisToru Tateno, Sylvia L Asa, Lei Zheng, et al.
Pageof 25